Oxidative stress in red blood cells, platelets and polymorphonuclear leukocytes from patients with myelodysplastic syndrome

European Journal of Haematology

Volumn 79, Issue 6, 2007, Pages 463-467

  Ghoti, Hussam ^a   Amer, Johnny ^b   Winder, Asher ^a   Rachmilewitz, Eliezer ^a   Fibach, Eitan ^b  

^a WOLFSON MEDICAL CENTER   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Anemia; Anti oxidants; Flow cytometry; Iron chelators; Iron overload; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; DEFERIPRONE; DEFEROXAMINE; FERRITIN; GLUTATHIONE; IRON CHELATING AGENT; REACTIVE OXYGEN METABOLITE;

AGED; ARTICLE; CELL STRESS; CONTROLLED STUDY; DRUG EFFECT; ERYTHROCYTE; FEMALE; FERRITIN BLOOD LEVEL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INCUBATION TIME; MALE; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; OXIDATIVE STRESS; PRIORITY JOURNAL; REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS; THROMBOCYTE;

ACETYLCYSTEINE; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; BLOOD PLATELETS; CHELATING AGENTS; DEFEROXAMINE; ERYTHROCYTES; FEMALE; HUMANS; MALE; MYELODYSPLASTIC SYNDROMES; NEUTROPHILS; OXIDATIVE STRESS; PYRIDONES;

EID: 36248937215     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2007.00972.x     Document Type: Article

References (19)

1. Anderson J. Allogeneic hematopoietic cell transplantation for myelodysplastic and myeloproliferative disorders. In : Thomas ED, Blume KG, Forman SJ, eds. Hematopoietic Cell Transplantation. Malden, MA : Blackwell Science, 1999 : 872 86.
2. Hershko C, Link G, Cabantchik I. Pathophysiology of iron overload. Ann N Y Acad Sci 1998 850 : 191 201.
3. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002 82 : 47 95.
4. Farquhar MJ, Bowen DT. Oxidative stress and the myelodysplastic syndromes. Int J Hematol 2003 77 : 342 50.
5. Amer J, Ghoti H, Rachmilewitz E, et al. Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants. Br J Haematol 2006 132 : 108 13.
6. Amer J, Fibach E. Oxidative status of platelets in normal and thalassemic blood. Thromb Haemost 2004 92 : 1052 9.
7. Amer J, Goldfarb A, Fibach E. Flow cytometric analysis of the oxidative status of normal and thalassemic red blood cells. Cytometry A 2004 60 : 73 80.
8. Amer J, Fibach E. Chronic oxidative stress reduces the respiratory burst response of neutrophils from beta-thalassaemia patients. Br J Haematol 2005 129 : 435 41.
9. Amer J, Etzion Z, Bookchin RM, et al. Oxidative status of valinomycin-resistant normal, beta-thalassemia and sickle red blood cells. Biochim Biophys Acta 2006 1760 : 793 9.
10. Gattermann N. Clinical consequences of iron overload in myelodysplastic syndromes and treatment with chelators. Hematol Oncol Clin North Am 2005 19 (Suppl. 1 13 17.
11. Raja KB, Pippard MJ, Simpson RJ, et al. Relationship between erythropoiesis and the enhanced intestinal uptake of ferric iron in hypoxia in the mouse. Br J Haematol 1986 64 : 587 93.
12. Winder A, Lefkowitz R, Ghoti H, et al. Urinary hepcidine excretion in patients with myelodysplastic syndrome (MDS) and myelofibrosis (MF). Blood 2006 108 : 740a.
13. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003 102 : 783 8.
14. Tehranchi R, Invernizzi R, Grandien A, et al. Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes. Blood 2005 106 : 247 53.
15. Jensen PD, Heickendorff L, Pedersen B, et al. The effect of iron chelation on haemopoiesis in MDS patients with transfusional iron overload. Br J Haematol 1996 94 : 288 99.
16. Greenberg PL, Young NS, Gattermann N. Myelodysplastic syndromes. Hematology (Am Soc Hematol Educ Program) 2002 : 136 61.
17. Bowen D, Culligan D, Jowitt S, et al. Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes. Br J Haematol 2003 120 : 187 200.
18. Iuliano L, Colavita AR, Leo R, et al. Oxygen free radicals and platelet activation. Free Radic Biol Med 1997 22 : 999 1006.
19. Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia. Blood 2002 99 : 36 43.